Results 281 to 290 of about 28,482,475 (369)

Proof of concept of a new plasma complement Factor H from waste plasma fraction. [PDF]

open access: yesFront Immunol
Mori F   +14 more
europepmc   +1 more source

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

open access: yesMolecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson   +11 more
wiley   +1 more source

Microglial reprogramming: a potential new frontier in enhancing immunotherapy for melanoma brain metastasis

open access: yesMolecular Oncology, EarlyView.
Microglia act as tumor suppressors during brain metastasis colonization but shift to a tumor‐promoting role after melanoma brain metastases form. NF‐κB/RelA signaling emerges as a key driver of this phenotypic shift. Targeting this pathway reprograms microglia into a pro‐inflammatory state, enhancing antitumor immunity and immune checkpoint inhibitor ...
Noam Savion‐Gaiger   +2 more
wiley   +1 more source

Mapping the interaction sites of human and avian influenza A viruses and complement factor H. [PDF]

open access: yesFront Immunol
Rabeeah I   +10 more
europepmc   +1 more source

Mapping the interaction sites of Influenza A viruses and human complement Factor H

open access: yes, 2023
Rabeeah I   +10 more
europepmc   +1 more source

Cleaving It All Behind: ADAMTS7 Degrades Factor H.

open access: yesJ Am Soc Nephrol, 2023
Heeger PS, Cravedi P.
europepmc   +1 more source

Identification and sequence analysis of four complement factor H-related transcripts in mouse liver.

open access: hybrid, 1990
D P Vik   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy